Scientists uncover how inflammatory molecules drive cancer progression
Colorectal cancer may resist immunotherapy not only because tumor cells acquire genetic changes, but also because inflammatory signals can reprogram ...
Colorectal cancer may resist immunotherapy not only because tumor cells acquire genetic changes, but also because inflammatory signals can reprogram ...
A new randomized Phase II clinical trial, OPTIM, is testing whether escalating immune therapy can improve outcomes for people with ...
In a groundbreaking study published in the June 2026 issue of Oncotarget, researchers from the Dana-Farber Cancer Institute have unveiled ...
A newly published study from Karolinska Institutet has illuminated a critical factor that may undermine the effectiveness of cancer immunotherapy—neutrophils, ...
For decades, the phenomenon of T cell exhaustion in tumors has puzzled immunologists and oncologists alike. Mitochondrial dysfunction has long ...
In a groundbreaking development that challenges prevailing paradigms of cancer immunotherapy resistance, researchers have unveiled a novel intrinsic mechanism by ...
In a groundbreaking international collaboration, researchers from Moffitt Cancer Center, the Karolinska Institutet, and the University of Texas MD Anderson ...
In a dramatic revelation that challenges conventional thinking about cell biology, scientists report that cancer cells can effectively “poison” the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine